miR122-controlled all-in-one nanoplatform for in situ theranostic of drug-induced liver injury by visualization imaging guided on-demand drug release

Drug-induced liver injury (DILI) is a challenging clinical problem with respect to both diagnosis and management. As a newly emerging biomarker of liver injury, miR122 shows great potential in early and sensitive in situ detection of DILI. Glycyrrhetinic acid (GA) possesses desirable therapeutic eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Lingchang, Wang, Qiaolei, Wang, Lai, Zhao, Zhen, Xin, Gui-Zhong, Zheng, Zuguo, Zhou, Ping, Li, Ping, Jiang, Yan, Li, Hui-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604687/
https://www.ncbi.nlm.nih.gov/pubmed/34825161
http://dx.doi.org/10.1016/j.mtbio.2021.100157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604687/
https://www.ncbi.nlm.nih.gov/pubmed/34825161
http://dx.doi.org/10.1016/j.mtbio.2021.100157

Ejemplares similares